Back to top
more

Amedisys (AMED)

(Real Time Quote from BATS)

$92.05 USD

92.05
66,687

+0.26 (0.28%)

Updated Apr 29, 2024 01:55 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Ensign Group's Inorganic Growth Impresses, Debt Level Hurts

Ensign Group's (ENSG) top line rises on inorganic and organic growth. Its financial health also impresses. However high level of costs and debts bother.

    Molina Healthcare's Top Line Grows on Membership, Debts Hurt

    Molina Healthcare's (MOH) top line benefits from inorganic growth and membership. However, rising level of debt and expenses hurt margins.

      WellCare Health Partners Mission Health to Improve Offerings

      WellCare Health Plans, Inc's (WCG) subsidiary, Wellcare of North Carolina recently entered into an agreement with Mission Health to provide better Medicaid and Medicare services in North Carolina.

        Centene (CNC) Poised to Grow on Buyouts, High Debt Bothers

        Centene's (CNC) accretive acquisitions backed by solid financials add to its top line. However, high debt and rising expenses hurt margins.

          Amedisys (AMED) Up 3.6% Since Earnings Report: Can It Continue?

          Amedisys (AMED) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

            Here's Why Chemed (CHE) is a Suitable Growth Pick for Now

            Banking on favorable Net Margin and ROE, Chemed (CHE) stands out as one of the most suitable growth stocks.

              IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why

              Banking on a number of favorable metrics, IDEXX Laboratories (IDXX) stands out as one of the most suitable growth stock.

                Is Amedisys (AMED) a Great Value Stock for Your Portfolio?

                Banking on a number of favorable metrics, Amedisys (AMED) stands out as one of the most suitable value stock.

                  Here's Why Masimo (MASI) is a Suitable Value Pick for Now

                  Masimo (MASI) seems to be a solid value pick with favorable P/E ratio and P/FCF ratio compared with its broader industry.

                    Here's Why Investors Should Buy Amedisys (AMED) Right Now

                    Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business.

                      Tabula Rasa Healthcare (TRHC) Catches Eye: Stock Up 9.5%

                      Tabula Rasa Healthcare, Inc. (TRHC) shares rose around 10% in the last trading session.

                        Aetna's (AET) $1 Billion Notes Due 2047 Rated By A.M Best

                        Rating Giant A.M Bests assigned a Long-Term Issue Credit Rating of "bbb" to Aetna's (AET) $1 billion, 3.875% senior notes due to mature on Aug 15, 2047.

                          Envision Healthcare Hurt by High Debt, Increasing Expenses

                          Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

                            Amedisys (AMED) Earnings & Revenues Miss Estimates in Q2

                            Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business in Q2.

                              Community Health Sells 2 Texas Units, Streamlines Business

                              Community Health Systems, Inc.'s (CYH) subsidiaries have sold their ownership interest in two Texas hospitals and their associated assets to subsidiaries of HCA Healthcare.

                                Amedisys (AMED) Prospects Impressive Amid Tough Competition

                                On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).

                                  Why Is Amedisys (AMED) Up 4% Since the Last Earnings Report?

                                  Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                    Amedisys (AMED) Beats on Q1 Earnings, Revenues Meet Mark

                                    Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 47 cents per share in the first quarter of 2017, up 42.4% year over year.

                                      Healthcare Q1 Earnings Slated on May 2: AET, HCA & More

                                      The healthcare sector has been in the limelight since the change of power at the White House.

                                        Amedisys (AMED) Poised on Strong Home Health, Risks Remain

                                        On Apr 04, we issued an updated research report on renowned home health and hospice services provider, Amedisys Inc. (AMED).

                                          Amedisys to Buy East Tennessee to Expand in Personal Care

                                          Amedisys Inc. (AMED) recently signed a definitive agreement to buy substantially all of the assets of a Knoxville, TN-based personal care provider, East Tennessee Personal Care Service.

                                            Amedisys Stock Up on Solid Earnings, Reimbursement Woes Stay

                                            On Mar 02, we issued an updated research report on renowned home health and hospice services provider Amedisys Inc. (AMED).

                                              Tenet Healthcare (THC) to Divest Operations to Amedisys

                                              Tenet Healthcare Corporation (THC) recently announced that it has inked a deal with Amedisys, Inc. (AMED) to divest its Home Health and Hospice operations in Arizona, Illinois, Massachusetts and Texas to the latter

                                                Amedisys (AMED) Catches Eye: Stock Gains 6.2% in Session

                                                Amedisys, Inc. (AMED) moved big last session, as its shares rose over 6% on the day.

                                                  Amedisys Buys 6 Home Health, Hospice Care Centers from Tenet

                                                  Amedisys Inc. (AMED), a household name in home health and hospice services space, recently signed an exclusive agreement with Tenet Healthcare Corporation (THC).